Intravenous Infusions is trading at GHS 0.55, up 3.77% on October 8, 2026; no specific company news has been identified to explain the rise.

  • The Ghana Stock Exchange listed the company’s October 23 annual general meeting notice on October 7; there is no evidence linking it to the share-price move.
  • Negative sector and global market context does not explain the gain.
  • No reliable volume or activity figure is available; price data is from the supplied context.